21062492|t|IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.
21062492|a|The contribution of inflammation to neurodegenerative diseases is increasingly recognized, but the role of inflammation in sporadic amyotrophic lateral sclerosis (sALS) is not well understood and no animal model is available. We used enzyme-linked immunosorbent assays (ELISAs) to measure the cytokine interleukin-17A (IL-17A) in the serum of ALS patients (n = 32; 28 sporadic ALS (sALS) and 4 familial ALS (fALS)) and control subjects (n = 14; 10 healthy subjects and 4 with autoimmune disorders). IL-17A serum concentrations were 5767 +- 2700 pg/ml (mean +- SEM) in sALS patients and 937 +- 927 pg/ml in fALS patients in comparison to 7 +- 2 pg/ml in control subjects without autoimmune disorders (p = 0.008 ALS patients vs. control subjects by Mann-Whitney test). Sixty-four percent of patients and no control subjects had IL-17A serum concentrations > 50 pg/ml (p = 0.003 ALS patients vs. healthy subjects by Fisher's exact test). The spinal cords of sALS (n = 8), but not control subjects (n = 4), were infiltrated by interleukin-1beta- (IL-1beta-), and tumor necrosis factor-alpha-positive macrophages (co-localizing with neurons), IL-17A-positive CD8 cells, and IL-17A-positive mast cells. Mononuclear cells treated with aggregated forms of wild type superoxide dismutase-1 (SOD-1) showed induction of the cytokines IL-1beta, interleukin-6 (IL-6), and interleukin-23 (IL-23) that may be responsible for induction of IL-17A. In a microarray analysis of 28,869 genes, stimulation of peripheral blood mononuclear cells by mutant superoxide dismutase-1 induced four-fold higher transcripts of interleukin-1alpha (IL-1alpha), IL-6, CCL20, matrix metallopeptidase 1, and tissue factor pathway inhibitor 2 in mononuclear cells of patients as compared to controls, whereas the anti-inflammatory cytokine interleukin-10 (IL-10) was increased in mononuclear cells of control subjects. Aggregated wild type SOD-1 in sALS neurons could induce in mononuclear cells the cytokines inducing chronic inflammation in sALS spinal cord, in particular IL-6 and IL-17A, damaging neurons. Immune modulation of chronic inflammation may be a new approach to sALS.
21062492	0	6	IL-17A	Gene	3605
21062492	52	55	CD8	Gene	925
21062492	74	77	ALS	Disease	MESH:D008113
21062492	78	86	patients	Species	9606
21062492	108	120	inflammation	Disease	MESH:D007249
21062492	124	150	neurodegenerative diseases	Disease	MESH:D019636
21062492	195	207	inflammation	Disease	MESH:D007249
21062492	211	249	sporadic amyotrophic lateral sclerosis	Disease	MESH:C531617
21062492	251	255	sALS	Disease	MESH:C531617
21062492	390	405	interleukin-17A	Gene	3605
21062492	407	413	IL-17A	Gene	3605
21062492	431	434	ALS	Disease	MESH:D008113
21062492	435	443	patients	Species	9606
21062492	456	468	sporadic ALS	Disease	MESH:D006528
21062492	470	474	sALS	Disease	MESH:C531617
21062492	491	494	ALS	Disease	MESH:D008113
21062492	496	500	fALS	Disease	MESH:C564190
21062492	564	584	autoimmune disorders	Disease	MESH:D001327
21062492	587	593	IL-17A	Gene	3605
21062492	656	660	sALS	Disease	MESH:C531617
21062492	661	669	patients	Species	9606
21062492	694	698	fALS	Disease	MESH:C564190
21062492	699	707	patients	Species	9606
21062492	766	786	autoimmune disorders	Disease	MESH:D001327
21062492	798	801	ALS	Disease	MESH:D008113
21062492	802	810	patients	Species	9606
21062492	877	885	patients	Species	9606
21062492	914	920	IL-17A	Gene	3605
21062492	964	967	ALS	Disease	MESH:D008113
21062492	968	976	patients	Species	9606
21062492	1043	1047	sALS	Disease	MESH:C531617
21062492	1111	1128	interleukin-1beta	Gene	3553
21062492	1131	1139	IL-1beta	Gene	3553
21062492	1147	1174	tumor necrosis factor-alpha	Gene	7124
21062492	1226	1232	IL-17A	Gene	3605
21062492	1242	1245	CD8	Gene	925
21062492	1257	1263	IL-17A	Gene	3605
21062492	1346	1368	superoxide dismutase-1	Gene	6647
21062492	1370	1375	SOD-1	Gene	6647
21062492	1411	1419	IL-1beta	Gene	3553
21062492	1421	1434	interleukin-6	Gene	3569
21062492	1436	1440	IL-6	Gene	3569
21062492	1447	1461	interleukin-23	Gene	27178
21062492	1463	1468	IL-23	Gene	27178
21062492	1511	1518	IL-17A.	Gene	3605
21062492	1621	1643	superoxide dismutase-1	Gene	6647
21062492	1684	1702	interleukin-1alpha	Gene	3552
21062492	1704	1713	IL-1alpha	Gene	3552
21062492	1716	1720	IL-6	Gene	3569
21062492	1722	1727	CCL20	Gene	6364
21062492	1729	1754	matrix metallopeptidase 1	Gene	4312
21062492	1760	1793	tissue factor pathway inhibitor 2	Gene	7980
21062492	1818	1826	patients	Species	9606
21062492	1869	1881	inflammatory	Disease	MESH:D007249
21062492	1891	1905	interleukin-10	Gene	3586
21062492	1907	1912	IL-10	Gene	3586
21062492	1991	1996	SOD-1	Gene	6647
21062492	2000	2004	sALS	Disease	MESH:C531617
21062492	2070	2090	chronic inflammation	Disease	MESH:D007249
21062492	2094	2098	sALS	Disease	MESH:C531617
21062492	2126	2130	IL-6	Gene	3569
21062492	2135	2141	IL-17A	Gene	3605
21062492	2182	2202	chronic inflammation	Disease	MESH:D007249
21062492	2228	2232	sALS	Disease	MESH:C531617
21062492	Association	MESH:C531617	7124
21062492	Positive_Correlation	3569	6647
21062492	Association	MESH:C531617	3605
21062492	Association	27178	3605
21062492	Association	MESH:D007249	3586
21062492	Positive_Correlation	3552	6647
21062492	Positive_Correlation	6364	6647
21062492	Association	3605	925
21062492	Positive_Correlation	27178	6647
21062492	Association	MESH:D008113	925
21062492	Association	MESH:C531617	925
21062492	Association	3569	3605
21062492	Positive_Correlation	3553	6647
21062492	Association	MESH:C531617	3553
21062492	Positive_Correlation	4312	6647
21062492	Association	3586	6647
21062492	Association	MESH:D008113	3605
21062492	Positive_Correlation	6647	7980

